Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes: the GLYMETY Study
Institut de Recherches Cliniques de Montreal
86 participants
May 2, 2022
OBSERVATIONAL
Conditions
Summary
In clinical practice, women living with type 1 diabetes frequently report that insulin requirements change across the menstrual cycle. Consequently, glycemic fluctuations are observed. This phenomenon could be explained by a decrease in insulin sensitivity during the second half of the menstrual cycle (luteal phase). Overall, despite an important proportion of women reporting glycemic and/or insulin variations across the menstrual cycle, studies to date have involved small sample sizes, and have had inconsistent results. The objective of this study will be to study glycemic fluctuations across the menstrual cycle using CGM data, alongside insulin data, in a large sample of women.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Glucose levels will be measured using continuous glucose monitoring
Insulin doses will be retrieved from insulin pump reports (for insulin pump users) or journals for (for multiple daily injections users)
Premenstrual symptoms will be assessed using the Premenstrual symptoms screening tool
Ovulation testing will be done using ovulation kits
Physical activity will be assessed using the Fitbit Inspire 2
Food intake will be assessed using the Keenoa phone application
The application My Calendar will be used to record information on the menstrual cycle
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05258292